Explore All Access
Check if your research matches the topics covered in Intractable and Rare Diseases Research?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Intractable and Rare Diseases Research : Impact Factor & More
eISSN: 2186-361XpISSN: 2186-3644
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Intractable and Rare Diseases Research Key Metrics
CiteScore 
2.4
SNIP
0.78
Intractable and Rare Diseases Research Journal Specifications
Indexed in the following public directories
Web of Science 
SJR
| Overview | |
| Publisher | INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT |
| Language | English |
| Frequency | Quarterly |
| General Details |
View less
Planning to publish in Intractable and Rare Diseases Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Intractable and Rare Diseases Research
A patient treated with ofatumumab for myasthenia gravis in conjunction with systemic lupus erythematosus and thyroid carcinoma.
- 31 Aug 2024
- Intractable & rare diseases research
Skeletal computed tomography findings of upper extremities in middle-aged persons with thalidomide embryopathy.
- 31 Aug 2024
- Intractable & rare diseases research
Spontaneous pneumomediastinum: A comprehensive review of diagnosis and management.
- 31 Aug 2024
- Intractable & rare diseases research
Guardians of memory: The urgency of early dementia screening in an aging society.
- 31 Aug 2024
- Intractable & rare diseases research
Cost-utility analysis of romiplostim for the treatment of chronic primary immune thrombocytopenia in China.
- 31 Aug 2024
- Intractable & rare diseases research
Genetic analysis of a novel FBN1 mutation in a pediatric Marfan syndrome patient.
- 31 Aug 2024
- Intractable & rare diseases research
A patient treated with ofatumumab for myasthenia gravis in conjunction with systemic lupus erythematosus and thyroid carcinoma.
- 31 Aug 2024
- Intractable & rare diseases research
Skeletal computed tomography findings of upper extremities in middle-aged persons with thalidomide embryopathy.
- 31 Aug 2024
- Intractable & rare diseases research
Spontaneous pneumomediastinum: A comprehensive review of diagnosis and management.
- 31 Aug 2024
- Intractable & rare diseases research
Guardians of memory: The urgency of early dementia screening in an aging society.
- 31 Aug 2024
- Intractable & rare diseases research
Cost-utility analysis of romiplostim for the treatment of chronic primary immune thrombocytopenia in China.
- 31 Aug 2024
- Intractable & rare diseases research
Genetic analysis of a novel FBN1 mutation in a pediatric Marfan syndrome patient.
- 31 Aug 2024
- Intractable & rare diseases research
FAQs on Intractable and Rare Diseases Research
How long has Intractable and Rare Diseases Research been actively publishing? 
Intractable and Rare Diseases Research has been in operation since 2012 till date.
What is the publishing frequency of Intractable and Rare Diseases Research?
Intractable and Rare Diseases Research published with a Quarterly frequency.
How many articles did Intractable and Rare Diseases Research publish last year?
In 2023, Intractable and Rare Diseases Research publsihed 40 articles.
What is the eISSN & pISSN for Intractable and Rare Diseases Research?
For Intractable and Rare Diseases Research, eISSN is 2186-361X and pISSN is 2186-3644.
What is Citescore for Intractable and Rare Diseases Research?
Citescore for Intractable and Rare Diseases Research is 2.4.
What is SNIP score for Intractable and Rare Diseases Research?
SNIP score for Intractable and Rare Diseases Research is 0.78.
Who is the publisher of Intractable and Rare Diseases Research?
INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT is the publisher of Intractable and Rare Diseases Research.
Your document is 100% secure & confidential 
